Abstract

ABSTRACT Dexamethasone (DEX) degradation was investigated using three UV-based advanced oxidation processes combined with sodium persulphate, hydrogen peroxide, and free chlorine in aqueous solutions in a bench-scale reactor. The goal was to determine which process would be the best option in terms of DEX degradation without the subsequent generation of toxic compounds. The process performance for DEX degradation followed the UV/S2O8 2−> UV/H2O2> UV/HOCl order under equal conditions. In the UV/S2O8 2− process, sulphate radicals led to a 70.4% DEX degradation. The experimental mineral inhibitory factors showed that nitrite and bicarbonate further decrease the efficiency of the UV/S2O8 2− process. In the optimal conditions, the UV/S2O8 −2 process removed DEX by 100% and had a 74.1% mineralisation. Furthermore, the intermediates were detected using LC-MS/MS, and the cytotoxicity of the UV/S2O8 −2 process effluent was evaluated using human embryonic kidney cultured cells. The treatment of DEX solution by the UV/S2O8 −2 process significantly decreased the toxicity of the effluent. Therefore, it can be concluded that the UV/S2O8 −2 process can be a reliable process for DEX degradation and detoxification in aqueous solutions.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.